Project Grant HT94252410935
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
The federal Project Grant award of $1,200,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to eliminate bone metastasis through a bone-targeting E-cadherin antibody nanogel. The research project, which has a performance period from April 1, 2025 to March 31, 2028, aims to advance medical solutions for the battlefield and transform healthcare for military service members and the...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $406,776.00 to Baylor University to develop a novel graft-localized drug delivery platform for reducing innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation. The 2-year project, spanning September 2024 to September 2026, aims to advance innovative biomedical research solutions to improve health outcomes for...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This $802,500 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports preclinical gene therapy studies in a mouse model of TSC2 at Baylor College of Medicine in Houston, Texas. The 3-year award period runs from May 1, 2025 to April 30, 2028 and aims to advance research on genetic disorders through innovative biomedical investigations. As a premier academic medical institution, Baylor...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
The Department of the Army Medical Command awarded Baylor College of Medicine a $10,087,552 project grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2026. The grant funds research on combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis. Specifically, Baylor College of Medicine and sub-awardees Cornell University ($401,517 each) will conduct preclinical studies to assess the prevention...
The Department of the Army Medical Command awarded Baylor College of Medicine a $320,000 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period of March 1, 2022 through February 29, 2024. The grant will support research into the anti-fibrotic effects of macropinocytosis inhibition in idiopathic pulmonary fibrosis. Through the Military Medical Research and Development program, the Department of the Army aims to transform military and public health...